The current state of introduction of HPV vaccination into national immunisation schedules in Europe: Results of the VENICE 2008 survey

Loretta Brabin, D. Lévy-Bruhl, V. Bousquet, L. A. King, D. O'Flanagan, S. Bacci, P. L. Lopalco, S. Salmaso

    Research output: Chapter in Book/Conference proceedingChapter

    Abstract

    Three surveys have been undertaken in European Union (EU) member states since January 2007, within the European Commission funded Vaccine European New Integrated Collaboration Effort (VENICE) project, to monitor the decision status regarding the introduction of human papillomavirus (HPV) vaccination into national immunisation schedules. A web-based questionnaire was developed and completed online by the 28 countries participating in VENICE. According to the last update (31st December 2008), 15 countries have decided to introduce HPV vaccination into their national immunisation schedule, while another six have started the decision-making process with a recommendation favouring introduction. Varying target populations have been selected by the countries which have introduced vaccination. The number of countries which have made a decision or recommendation has increased from 12 to 21 between October 2007 and December 2008. This survey demonstrates the rapidly evolving nature of HPV vaccine introduction in Europe. A further update should be available in the second half of 2009. © 2009 Elsevier Ltd. All rights reserved.
    Original languageEnglish
    Title of host publicationEuropean Journal of Cancer|Eur. J. Cancer
    PublisherOxford University Press
    Pages2709-2713
    Number of pages4
    Volume45
    DOIs
    Publication statusPublished - Oct 2009

    Keywords

    • Europe
    • HPV
    • Vaccine

    Fingerprint

    Dive into the research topics of 'The current state of introduction of HPV vaccination into national immunisation schedules in Europe: Results of the VENICE 2008 survey'. Together they form a unique fingerprint.

    Cite this